Jennifer R Diamond Selected Research

Jennifer R Diamond Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 12/2009
24	Triple Negative Breast Neoplasms 01/2024 - 01/2013
16	Breast Neoplasms (Breast Cancer) 06/2023 - 06/2009
9	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 02/2011
6	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 06/2010
3	Brain Neoplasms (Brain Tumor) 06/2022 - 07/2014
3	Disease Progression 01/2022 - 01/2018
2	Adenocarcinoma 04/2024 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2024 - 10/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2015
2	Melanoma (Melanoma, Malignant) 12/2023 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2023 - 08/2022
2	Neutropenia 01/2022 - 01/2017
2	Aneuploidy (Aneuploid) 11/2019 - 10/2018
1	Endometrial Neoplasms (Endometrial Cancer) 02/2024
1	Heart Failure 11/2023
1	Cardiotoxicity 11/2023
1	Cardiac Arrhythmias (Arrythmia) 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2023
1	Myocardial Infarction 11/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2023
1	Central Nervous System Diseases (CNS Diseases) 06/2023
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Anemia 01/2022
1	Hyponatremia 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 02/2021
1	Paraneoplastic Cerebellar Degeneration 02/2021
1	Encephalitis (Encephalitis, Rasmussen) 02/2021

Drug/Important Bio-Agent (IBA)

10	Phosphotransferases (Kinase)IBA 10/2022 - 06/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
6	ENMD 2076IBA 10/2018 - 06/2010
5	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 12/2018
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2015
5	Hormones (Hormone)IBA 02/2021 - 03/2020
4	MLN 8237IBA 04/2024 - 05/2015
4	Aurora Kinase AIBA 04/2024 - 06/2010
4	PlatinumIBA 12/2023 - 02/2011
4	sacituzumab govitecanIBA 06/2022 - 07/2017
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
4	CateninsIBA 11/2020 - 03/2014
3	sapanisertibIBA 04/2024 - 01/2020
3	Histone Deacetylase InhibitorsIBA 01/2024 - 01/2022
3	taxaneIBA 11/2023 - 01/2022
3	atezolizumabIBA 01/2021 - 01/2019
2	Mechanistic Target of Rapamycin Complex 1IBA 04/2024 - 01/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 12/2023 - 01/2022
2	AnthracyclinesIBA 11/2023 - 01/2023
2	Fulvestrant (Faslodex)FDA Link 05/2023 - 01/2021
2	Topoisomerase I InhibitorsIBA 10/2022 - 10/2017
2	ErbB Receptors (EGF Receptor)IBA 02/2021 - 07/2014
2	adavosertibIBA 01/2021 - 03/2020
2	Capecitabine (Xeloda)FDA Link 01/2021 - 03/2020
2	RX-5902IBA 11/2020 - 11/2019
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2019
2	Ado-Trastuzumab EmtansineIBA 01/2019 - 07/2014
2	Monoclonal AntibodiesIBA 01/2019 - 06/2015
2	Immunoconjugates (Immunoconjugate)IBA 07/2017 - 03/2016
2	Aurora KinasesIBA 01/2013 - 02/2011
1	monalizumabIBA 02/2024
1	LigandsIBA 02/2024
1	durvalumabIBA 02/2024
1	Granzymes (Granzyme)IBA 02/2024
1	ChemokinesIBA 02/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	binimetinibIBA 12/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023
1	DepsipeptidesIBA 12/2023
1	omega-Chloroacetophenone (Mace)IBA 11/2023
1	trastuzumab deruxtecanIBA 07/2023
1	Cyclin D1IBA 06/2023
1	Letrozole (Femara)FDA LinkGeneric 06/2023
1	palbociclibIBA 06/2023
1	tucatinibIBA 06/2023
1	Aromatase InhibitorsIBA 06/2023
1	AndrogensIBA 05/2023
1	enzalutamideIBA 05/2023
1	Fluorouracil (Carac)FDA LinkGeneric 10/2022
1	AZD0156IBA 10/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2022
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	Alkaline PhosphataseIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Cyclin-Dependent Kinase 9IBA 01/2022
1	pertuzumabIBA 06/2021
1	Trastuzumab (Herceptin)FDA Link 06/2021
1	neratinibIBA 06/2021
1	AntibodiesIBA 02/2021
1	anti-Yo autoantibodiesIBA 02/2021
1	human ERBB2 proteinIBA 02/2021
1	pembrolizumabIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021

Therapy/Procedure

16	Therapeutics 04/2024 - 06/2009
10	Drug Therapy (Chemotherapy) 11/2023 - 01/2014
3	Adjuvant Chemotherapy 11/2023 - 01/2022
2	Immunotherapy 01/2021 - 01/2021
1	Oral Administration 01/2022